Researchers continue the fight against Choroideremia
Following on from a successful world’s first Phase I gene therapy trial for choroideremia, Professor Robert MacLaren and his team have started a Phase II trial enrolling 30 patients. The project has been funded by the EME Programme, an MRC and NIHR partnership.In this trial, Professor MacLaren is using an operating microscope with integrated optical...
Source: NIHR Evaluation, Trials and Studies News - Category: American Health Source Type: news
More News: American Health | Gene Therapy | Genetics | National Institute for Health Research (NIHR) | Partnerships | Study